When I was working at one of the largest biotechnology companies in the world, the CEO said to me “Ithink this century is about biotech. In eighty years, people are going to smile about diseases that we needed to deal with and we couldn’t treat, and we couldn’t cure, and it’s all history.”
As we move into the second half of 2020 and our fifth month since the novel coronavirus has caused shut downs of varying degrees across the nation and the world, the question in the forefront of…
When it comes to the novel coronavirus pandemic, broaching the topic of antibodies can quickly see it spinning into a million different questions. What exactly are antibodies? Does everybody infected with the virus produce them? If so, how long do they last? Can those antibodies be used to treat those suffering from severe symptoms of COVID-19?
For many young professionals, reaching a leadership stance within their respective professional trajectory is an accomplishment worth celebrating. After garnering an extensive education, working diligently to gain pertinent experience, and proverbially cutting their teeth to rise amongst the ranks of a particular company, these young professionals prove to be the most worthy of leadership roles, promotion, and management titles.